Asset
TIRASEMTIV
Cytokinetics Incorporated Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01378676 | phase2 | completed | 2011-06-01 | 2012-03-01 | Cytokinetics | A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) |
| NCT01486849 | phase2 | completed | 2011-11-01 | 2012-03-01 | Cytokinetics | Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) |
| NCT01709149 | phase2 | completed | 2012-10-01 | 2014-03-01 | Cytokinetics | Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) |
FDA applications (0)
This company has no applications containing this asset.